1800 OWENS STREET, SAN FRANCISCO, CA
Market cap: $1.0B (2/08/2026)
Price: $7.28
Investor Presentation
Vir Biotech Licenses Hepatitis Delta Treatment in Europe, Australia, & NZ
Earnings Release
Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN™ Dual-Masked T-Cell Engager for the Treatment of Solid Tumors
Shareholder votes
Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study
Provides Corporate Update and Reports First Quarter 2025 Financial Results
Q3
Q2
FY 2023
Q1
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(4)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
S-1MEF
Correspondence
Submission Upload